Maxcyte Inc (MXCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,557 | 20,065 | 12,973 | 15,225 | 23,385 |
| Marketable Securities | 92,297 | 82,979 | 92,755 | 111,337 | 114,885 |
| Receivables | 4,246 | 3,503 | 8,306 | 5,753 | 5,525 |
| Inventories | 7,631 | 7,547 | 7,611 | 7,933 | 8,274 |
| TOTAL | $122,937 | $118,369 | $124,645 | $143,219 | $155,748 |
| Non-Current Assets | |||||
| PPE Net | 16,637 | 17,531 | 18,620 | 19,404 | 19,921 |
| Investments And Advances | 40,811 | 52,570 | 52,274 | 38,600 | 36,423 |
| Intangibles | 783 | 650 | 4,221 | 4,386 | 4,417 |
| Other Non-Current Assets | 13,305 | 13,387 | 13,716 | 14,141 | 13,452 |
| TOTAL | $71,536 | $84,138 | $88,831 | $76,531 | $74,213 |
| Total Assets | $194,473 | $202,507 | $213,476 | $219,750 | $229,961 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,196 | 1,401 | 1,286 | 1,210 | 2,279 |
| Accrued Expenses | 4,371 | 7,812 | 8,306 | 6,397 | 5,033 |
| TOTAL | $10,212 | $14,267 | $16,102 | $11,555 | $12,733 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,271 | 3,598 | 5,196 | 2,640 | 4,145 |
| Other Non-Current Liabilities | 16,375 | 16,750 | 17,099 | 17,472 | 17,816 |
| TOTAL | $16,375 | $16,750 | $17,099 | $17,472 | $17,816 |
| Total Liabilities | $26,587 | $31,017 | $33,201 | $29,027 | $30,549 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 107,122 | 106,861 | 106,674 | 106,607 | 106,319 |
| Common Shares | 1,071 | 1,068 | 1,066 | 1,066 | 1,063 |
| Retained earnings | -266,233 | -261,483 | -251,887 | -239,471 | -227,114 |
| TOTAL | $167,886 | $171,490 | $180,275 | $190,723 | $199,412 |
| Total Liabilities And Equity | $194,473 | $202,507 | $213,476 | $219,750 | $229,961 |